Literature DB >> 11854180

Toll receptors: a central element in innate immune responses.

Thierry Vasselon1, Patricia A Detmers.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 11854180      PMCID: PMC127779          DOI: 10.1128/IAI.70.3.1033-1041.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


× No keyword cloud information.
  123 in total

1.  Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin.

Authors:  A M Hajjar; D S O'Mahony; A Ozinsky; D M Underhill; A Aderem; S J Klebanoff; C B Wilson
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

2.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

Review 3.  How do you see CG?

Authors:  A Aderem; D A Hume
Journal:  Cell       Date:  2000-12-22       Impact factor: 41.582

4.  The extra domain A of fibronectin activates Toll-like receptor 4.

Authors:  Y Okamura; M Watari; E S Jerud; D W Young; S T Ishizaka; J Rose; J C Chow; J F Strauss
Journal:  J Biol Chem       Date:  2001-01-09       Impact factor: 5.157

5.  MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components.

Authors:  R Dziarski; Q Wang; K Miyake; C J Kirschning; D Gupta
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

6.  Micrococci and peptidoglycan activate TLR2-->MyD88-->IRAK-->TRAF-->NIK-->IKK-->NF-kappaB signal transduction pathway that induces transcription of interleukin-8.

Authors:  Q Wang; R Dziarski; C J Kirschning; M Muzio; D Gupta
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

7.  Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells.

Authors:  T Chuang; R J Ulevitch
Journal:  Biochim Biophys Acta       Date:  2001-03-19

8.  Evidence for an accessory protein function for Toll-like receptor 1 in anti-bacterial responses.

Authors:  D H Wyllie; E Kiss-Toth; A Visintin; S C Smith; S Boussouf; D M Segal; G W Duff; S K Dower
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

9.  Mycoplasma fermentans lipoprotein M161Ag-induced cell activation is mediated by Toll-like receptor 2: role of N-terminal hydrophobic portion in its multiple functions.

Authors:  M Nishiguchi; M Matsumoto; T Takao; M Hoshino; Y Shimonishi; S Tsuji; N A Begum; O Takeuchi; S Akira; K Toyoshima; T Seya
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

10.  Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus.

Authors:  S Morath; A Geyer; T Hartung
Journal:  J Exp Med       Date:  2001-02-05       Impact factor: 14.307

View more
  52 in total

1.  Using Linear Discriminant Analysis to Characterize Novel Single Nucleotide Polymorphisms and Expression Profile Changes in Genes of Three Breeds of Rabbit (Oryctolagus cuniculus).

Authors:  Ahmed I Ateya; Basma M Hendam; Hend A Radwan; Eman A Abo Elfadl; Mona M Al-Sharif
Journal:  Comp Med       Date:  2021-05-25       Impact factor: 0.982

Review 2.  Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen).

Authors:  Robert R Brubaker
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

Review 3.  Advances in the management of sepsis and the understanding of key immunologic defects.

Authors:  Lee P Skrupky; Paul W Kerby; Richard S Hotchkiss
Journal:  Anesthesiology       Date:  2011-12       Impact factor: 7.892

4.  Involvement of toll-like receptor 2 in experimental invasive pulmonary aspergillosis.

Authors:  Viviane Balloy; Mustapha Si-Tahar; Osamu Takeuchi; Bruno Philippe; Marie-Anne Nahori; Myriam Tanguy; Michel Huerre; Shizuo Akira; Jean-Paul Latgé; Michel Chignard
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

5.  Differential roles of Toll-like receptors 2 and 4 in in vitro responses of macrophages to Legionella pneumophila.

Authors:  Morikazu Akamine; Futoshi Higa; Noriko Arakaki; Kazuyoshi Kawakami; Kiyoshi Takeda; Shizuo Akira; Atsushi Saito
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 6.  Lost in translation--basic science in the era of translational research.

Authors:  Ferric C Fang; Arturo Casadevall
Journal:  Infect Immun       Date:  2009-12-28       Impact factor: 3.441

7.  Role of Toll-like receptor 4 in induction of cell-mediated immunity and resistance to Brucella abortus infection in mice.

Authors:  Marco A Campos; Gracia M S Rosinha; Igor C Almeida; Xirlene S Salgueiro; Bruce W Jarvis; Gary A Splitter; Nilofer Qureshi; Oscar Bruna-Romero; Ricardo T Gazzinelli; Sergio C Oliveira
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Diversity and evolution of 11 innate immune genes in Bos taurus taurus and Bos taurus indicus cattle.

Authors:  Christopher M Seabury; Paul M Seabury; Jared E Decker; Robert D Schnabel; Jeremy F Taylor; James E Womack
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

9.  Lack of Toll-like receptor 4 and 2 polymorphisms in Korean patients with bacteremia.

Authors:  Hee Jung Yoon; Jun Yong Choi; Chang Oh Kim; Yoon Seon Park; Myoung Soo Kim; Young Keun Kim; So Youn Shin; June Myung Kim; Young Goo Song
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

10.  Membrane-anchored CD14 is important for induction of interleukin-8 by lipopolysaccharide and peptidoglycan in uroepithelial cells.

Authors:  Toshiaki Shimizu; Shin-ichi Yokota; Satoshi Takahashi; Yasuharu Kunishima; Koh Takeyama; Naoya Masumori; Atsushi Takahashi; Masanori Matsukawa; Naoki Itoh; Taiji Tsukamoto; Nobuhiro Fujii
Journal:  Clin Diagn Lab Immunol       Date:  2004-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.